Shuai Ren
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 25
-
- Radiomics and Machine Learning in Medical Imaging 11
-
- Cancer, Hypoxia, and Metabolism 7
-
- Renal cell carcinoma treatment 6
-
- Neuroendocrine Tumor Research Advances 11
-
- Pancreatitis Pathology and Treatment 8
-
- Nanoplatforms for cancer theranostics 8
-
- Nanoparticle-Based Drug Delivery 7
- Co-authors
- Zhongqiu WangKai GuoShaofeng DuanXiaohong ChenWenli QiuXiao ChenYingying CaoXiangxiang Zhou
- Journals
- SHILAP Revista de lepidopterología (2 papers)Blood (6 papers)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesTürkiye
In The Last Decade
Shuai Ren
69 papers receiving 864 citations
Peers
Comparison fields: 5 of 90
- Oncology 410
- Radiology, Nuclear Medicine and Imaging 255
- Cancer Research 87
- Pulmonary and Respiratory Medicine 147
- Health Informatics 6
Countries citing papers authored by Shuai Ren
This map shows the geographic impact of Shuai Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuai Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuai Ren more than expected).
Fields of papers citing papers by Shuai Ren
This network shows the impact of papers produced by Shuai Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuai Ren. The network helps show where Shuai Ren may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuai Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 6 | |
| 13 | 2021 | 18 | |
| 14 | 2021 | 70 | |
| 15 | 2021 | 5 | |
| 16 | 2021 | 16 | |
| 17 | 2021 | 6 | |
| 18 | 2020 | 34 | |
| 19 | 2018 | 1 | |
| 20 | 2018 | 11 |
About Shuai Ren
Shuai Ren is a scholar working on Oncology, Cancer Research and Gastroenterology, having authored 75 papers that have together received 873 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (25 papers), Radiomics and Machine Learning in Medical Imaging (11 papers), Neuroendocrine Tumor Research Advances (11 papers), Pancreatitis Pathology and Treatment (8 papers), Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Renal cell carcinoma treatment (6 papers). The work is most often cited by research in Oncology (410 citations), Radiology, Nuclear Medicine and Imaging (255 citations) and Cancer Research (87 citations). Shuai Ren has collaborated with scholars based in China, United States and Türkiye. Frequent co-authors include Zhongqiu Wang, Kai Guo, Shaofeng Duan, Xiaohong Chen, Wenli Qiu, Xiao Chen, Yingying Cao, Xiangxiang Zhou, Shunfeng Hu and Rong Chen. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.